EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP

Victoria Maddox iD, Pamela Vallely, Susan R Brailsford, Heli Harvala iD

Transfusion Medicine · 2023

DOI: 10.1111/tme.12993 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transfusion Medicine, 2023. Verfasst von Victoria Maddox und 3 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology Services, NHS Blood and Transplant, London, UK. Hauptthemen laut MEDLINE: Blood Donors, HIV Infections, Safety Management, Blood Donation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A more individualised donor selection policy was implemented in the UK in 2021, which replaced the previous 3‐month deferral for men who have sex with men (MSM). Other blood services have a variety of policies in place to ensure the virological safety of blood components, ranging from an indefinite ban on MSM, to a defined period of exclusion, or to an individualised risk assessment that is not based on gender or sexual orientation. Justification of these policies should be based on scientific evidence including assessment of lengths of virological window periods, infectious disease epidemiology within donor populations and donation screening assay sensitivities. Developments in molecular technology and assays which can detect both antibodies and antigens in the very early stages of infection have significantly reduced the risk in most developed countries. However, the increasing usage of pre‐exposure prophylaxis (PrEP) to prevent acquisition of HIV infection after possible high‐risk sexual contact within the UK blood donor population has been recently noted. It has brought with it new diagnostic challenges within blood screening, notably possible non‐detection of HIV RNA and serological markers following PrEP use despite potential infectivity. The use of other testing strategies such as detection of HIV DNA and screening for non‐declared PrEP usage should be investigated further.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood DonorsHIV InfectionsSafety ManagementBlood DonationHIVPre-Exposure ProphylaxisFemaleHumansMaleHomosexuality, MaleRisk AssessmentSexual and Gender MinoritiesUnited KingdomAntiviral Agents

Stichwörter der Autor:innen

HIVPrEPblood donationblood safetydonor deferral

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Microbiology Services, NHS Blood and Transplant, London, UK.
  • Division of Evolution, Infection and Genomics Science, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.

ORCID-Profile: Victoria Maddox, Heli Harvala

Zitieren

APA

Maddox, V., Vallely, P., Brailsford, S. R., & Harvala, H. (2023). Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP. Transfusion Medicine. https://doi.org/10.1111/tme.12993

Vancouver

Maddox V, Vallely P, Brailsford SR, Harvala H. Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP. Transfusion Medicine. 2023. doi:10.1111/tme.12993

BibTeX
@article{Maddox2023,
  author = {Maddox, Victoria and Vallely, Pamela and Brailsford, Susan R and Harvala, Heli},
  title = {Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP},
  journal = {Transfusion Medicine},
  year = {2023},
  doi = {10.1111/tme.12993}
}
Kostenlos starten →